Announced Tue, 25 Nov · 13:56 IST

The board has considered and accepted the Resignation of Mrs . Dakshita Jain as Non Executive Independent Director of the company w.e.f. November 24, 2025.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mrs. Dakshita Jain has resigned from her position as Non-Executive Independent Director of Venmax Drugs and Pharmaceuticals Ltd, effective November 24, 2025. The board accepted her resignation at a meeting held on the same day (5:00 PM to 5:30 PM). She cited personal and professional commitments (pre-occupations) as the reason and confirmed there are no other material reasons for her exit. She held no other listed-entity directorships or board committee positions. The company has filed the disclosure under SEBI Listing Regulations and enclosed her resignation letter.

Likely market impact

This is a routine independent director exit for personal reasons with no governance red flags, so the impact on shareholders is likely neutral. Investors should watch for the timely appointment of a replacement independent director to maintain board composition requirements.